CRISPR/Cas9-mediated γ-globin expression upregulation in HEK293T cells
Objective To edit the γ-globin promoter of HEK293T cells using the CRISPR/Cas9 technology to upregulate γ-globin and explore the feasibility of using gene editing technology for the treatment of β-thalassemia. Methods Using gene editing technology to treat β-thalassemia, two sgRNA sequences were des...
Saved in:
| Main Authors: | HUANG Xianjuan, LAI Yongrong, LI Jing |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Guangxi Medical University
2025-04-01
|
| Series: | Guangxi Yike Daxue xuebao |
| Subjects: | |
| Online Access: | https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2025.02.011 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhanced membrane protein production in HEK293T cells via ATF4 gene knockout: A CRISPR-Cas9 mediated approach
by: Byung-Jo Choi, et al.
Published: (2025-01-01) -
Development of HEK293T cell reference materials for β-thalassemia genetic testing using prime editing
by: Ren Baoyan, et al.
Published: (2025-01-01) -
Evaluation of the Molecular Effects of the Anticancer Adjuvant Valproic Acid on HEK293T Cells
by: Feyza Nur Tuncer, et al.
Published: (2024-12-01) -
Nanotechnology-Based Delivery of CRISPR/Cas9 for Cancer Treatment: A Comprehensive Review
by: Mohd Ahmar Rauf, et al.
Published: (2025-07-01) -
The CRISPR/Cas system: Gene Editing by bacterial defense
by: Amira H. El-Ashry
Published: (2023-09-01)